T1	Participants 123 151	metastatic renal cell cancer
T2	Participants 211 268	maintenance immunotherapy in metastatic renal cell cancer
T3	Participants 783 873	One hundred and eighty-three patients were enrolled between January 1998 and November 2003
T4	Participants 1165 1208	use of chemotherapy after first progression
T5	Participants 1299 1312	female gender
